Startseite Association of nucleated red blood cells in blood and arterial oxygen partial tension
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Association of nucleated red blood cells in blood and arterial oxygen partial tension

  • Sandra Kuert EMAIL logo , Tim Holland-Letz , Jochen Friese und Axel Stachon
Veröffentlicht/Copyright: 1. Dezember 2010
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Several studies suggest that the detection of nucleated red blood cells (NRBCs) in hospitalized patients indicates an increased risk of mortality. This study evaluates the impact of low arterial oxygen partial tension (pO2) on NRBC appearance and prognosis in NRBC positive patients.

Methods: NRBCs in blood, arterial blood gases, and other laboratory parameters were monitored daily in 234 surgical intensive care patients. pO2 was assessed in relation to mortality and the detection of NRBCs.

Results: NRBCs were found in 67 patients (28.6%). Mortality was significantly higher in NRBC positive patients (41.8%, 28/67) than in those that were NRBC negative (3.0%, 5/167). Multivariate logistic regression showed an increased mortality in NRBC positive patients (odds ratio 5.79; 95% confidence interval (CI) 1.07–31.33, p<0.05). NRBC positive patients showed significantly lower pO2 levels during intensive care treatment than NRBC negative patients. Prior to the initial detection of NRBCs in the peripheral blood, pO2 levels were significantly lower in patients who died than in surviving patients. After the first appearance of NRBCs, no significant difference in pO2 between these groups was found.

Conclusions: The detection of NRBCs is of prognostic significance concerning patient mortality. In NRBC positive patients, hypoxemia occurs more frequently. Low-levels of pO2 seem to precede the appearance of NRBCs, especially in those patients with high risk of mortality.


Corresponding author: Sandra Kuert, Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, BG-University Hospital Bergmannsheil, Ruhr-University, Buerkle-de-la-Camp-Platz 1, Bochum 44789, Germany Phone: +49-234-302-0, Fax: +49-234-302-6614

Received: 2010-3-31
Accepted: 2010-9-24
Published Online: 2010-12-1
Published in Print: 2011-02-01

©2011 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Editorial
  2. Hepcidin: the main regulator of iron homeostasis
  3. Reviews
  4. Global trends in critical values practices and their harmonization
  5. Ischemia modified albumin changes – review and clinical implications
  6. Genetics and Molecular Diagnostics
  7. Decreased serum brain-derived neurotrophic factor (BDNF) is associated with post-stroke depression but not with BDNF gene Val66Met polymorphism
  8. A novel liquidchip platform for simultaneous detection of 70 alleles of DNA somatic mutations on EGFR, KRAS, BRAF and PIK3CA from formalin-fixed and paraffin-embedded slides containing tumor tissue
  9. General Clinical Chemistry and Laboratory Medicine
  10. Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload
  11. Serum hepcidin-25 in comparison to biochemical markers and hematological indices for the differentiation of iron-restricted erythropoiesis
  12. The quality of the extra-analytical phase of laboratory practice in some developing European countries and Mexico – a multicentric study
  13. Impact of cryopreservation on serum concentration of matrix metalloproteinases (MMP)-7, TIMP-1, vascular growth factors (VEGF) and VEGF-R2 in Biobank samples
  14. Determinants of circulating asymmetric and symmetric dimethylarginines in patients evaluated for acute dyspnea
  15. Urinary stone composition in pediatric patients: a retrospective study of 205 cases
  16. Electrolyte-balanced heparin in blood gas syringes can introduce a significant bias in the measurement of positively charged electrolytes
  17. Full-scan mass spectral evidence for 3-epi-25-hydroxyvitamin D3 in serum of infants and adults
  18. Association of nucleated red blood cells in blood and arterial oxygen partial tension
  19. Validation and Outcome Studies
  20. Cystatin C is a reliable marker for estimation of glomerular filtration rate in renal transplantation: validation of a new turbidimetric assay using monospecific sheep antibodies
  21. Analytical validation of the Liaison Calcitonin_II-Gen (DiaSorin)
  22. A new tool in the field of in-vitro diagnosis of allergy: preliminary results in the comparison of ImmunoCAP© 250 with the ImmunoCAP© ISAC
  23. Rapid microwave digestion and microplate reading format method for urinary iodine determination
  24. Reference Values and Biological Variations
  25. Serum creatinine concentrations in male and female elite swimmers. Correlation with body mass index and evaluation of estimated glomerular filtration rate
  26. Biological variation of free β chorionic gonadotropin and pregnancy-associated plasma protein A in first trimester pregnancies
  27. Non-infectious conditions and gestational age influence C-reactive protein values in newborns during the first 3 days of life
  28. Cancer Diagnostics
  29. Interpretation of increments in serial tumour biomarker concentrations depends on the distance of the baseline concentration from the cut-off
  30. Performance of nuclear matrix protein 22 urine marker and voided urine cytology in the detection of urinary bladder tumors
  31. High-performance metabolic marker assessment in breast cancer tissue by mass spectrometry
  32. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience
  33. Letters to the Editor
  34. Stat laboratory timeliness management according to clinician needs
  35. Stability of serum samples and hemolysis interference on the high sensitivity troponin T assay
  36. Falsely diminished results for insulin concentrations measured with the IMMULITE® 2000
  37. Neutrophil gelatinase-associated lipocalin (NGAL) determined in urine with the Abbott Architect or in plasma with the Biosite Triage? The laboratory's point of view
Heruntergeladen am 4.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2011.041/html?lang=de
Button zum nach oben scrollen